Comparison of RTP dose distributions in heterogeneous phantoms with the beam Monte Carlo simulation system

Therapeutic treatment plan evaluation is often based on examining the radiotherapy treatment planning (RTP) system dose distributions in the target and surrounding normal structures. To study the effects of tissue inhomogeneities on photon dose distributions, we compared FOCUS RTP system dose distri...

Full description

Saved in:
Bibliographic Details
Published inJournal of applied clinical medical physics Vol. 2; no. 1; pp. 21 - 31
Main Authors Miften, Moyed, Wiesmeyer, Mark, Kapur, Ajay, Ma, C.‐M. Charlie
Format Journal Article
LanguageEnglish
Published Hoboken John Wiley and Sons Inc 2001
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Therapeutic treatment plan evaluation is often based on examining the radiotherapy treatment planning (RTP) system dose distributions in the target and surrounding normal structures. To study the effects of tissue inhomogeneities on photon dose distributions, we compared FOCUS RTP system dose distributions from the measurement‐based Clarkson and model‐based MultiGrid Superposition (MGS) algorithms with those from the beam Monte Carlo code system in a set of heterogeneous phantoms. The phantom inhomogeneities mimic relevant clinical treatment sites, which include lung slab, lung‐bone slab, bone‐lung slab, mediastinum, and tumor geometries. The benchmark comparisons were performed in lung densities of 0.20 and 0.31g/cm3, and a bone density of 2.40g/cm3 for 5×5cm2 and 10×10cm2,6− and 15‐MV photon beams. Benchmark comparison results show that the MGS model and beam doses match better than 3% or 3 mm, and the MGS model is more accurate than the Clarkson model in all phantoms. The MGS model, unlike the Clarkson model, predicts the build‐down and build‐up of dose near tissue interfaces and penumbra broadening in lung associated with high energy beams. The Clarkson model overestimates the dose in lung by a maximum of 10% compared to beam. Dose comparisons suggest turning‐off the effective path length inhomogeneity correction in the Clarkson model for lung treatments. PACS number(s): 87.53.–j, 87.53.Bn
ISSN:1526-9914
1526-9914
DOI:10.1120/jacmp.v2i1.2623